| 1 |
30717701 | Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure. | 2019 Feb 4 |
1 |
| 2 |
30923410 | The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells. | 2019 Feb 28 |
1 |
| 3 |
31100944 | Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis. | 2019 May 16 |
1 |
| 4 |
31406244 | FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma. | 2019 Oct |
2 |
| 5 |
30091530 | ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid. | 2018 Sep |
1 |
| 6 |
28267674 | The effects of SAHA on radiosensitivity in pancreatic cancer cells by inducing apoptosis and targeting RAD51. | 2017 May |
1 |
| 7 |
29212192 | Vorinostat and metformin sensitize EGFR-TKI resistant NSCLC cells via BIM-dependent apoptosis induction. | 2017 Nov 7 |
1 |
| 8 |
26050346 | Sensitization of suberoylanilide hydroxamic acid (SAHA) on chemoradiation for human cervical cancer cells and its mechanism. | 2015 |
3 |
| 9 |
24814395 | Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA. | 2014 Aug 28 |
1 |
| 10 |
25139025 | Co-administration of ABT-737 and SAHA induces apoptosis, mediated by Noxa upregulation, Bax activation and mitochondrial dysfunction in PTEN-intact malignant human glioma cell lines. | 2014 Dec |
1 |
| 11 |
25261655 | Effects and mechanism of suberoylanilide hydroxamic acid on the proliferation and apoptosis of human hepatoma cell line Bel-7402. | 2014 Jul-Sep |
2 |
| 12 |
25546354 | Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms. | 2014 |
1 |
| 13 |
22086447 | Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage. | 2013 Feb |
1 |
| 14 |
24278362 | Chemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expression. | 2013 |
1 |
| 15 |
21652541 | Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters. | 2011 Jun 15 |
1 |
| 16 |
21472287 | Synergistic induction of apoptosis in HeLa cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitor SAHA. | 2010 Jul-Aug |
1 |
| 17 |
18694296 | Histone deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. | 2009 May |
1 |
| 18 |
18166465 | Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts. | 2008 Mar 15 |
1 |
| 19 |
18310471 | Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. | 2008 Jun |
1 |
| 20 |
18765530 | Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. | 2008 Sep 1 |
1 |
| 21 |
18065490 | Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells. | 2007 Dec |
1 |
| 22 |
16550602 | The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. | 2006 Aug 15 |
1 |
| 23 |
15625278 | Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change. | 2005 Apr |
1 |
| 24 |
15897598 | Novel histone deacetylase inhibitors in the treatment of thyroid cancer. | 2005 May 15 |
1 |
| 25 |
16297208 | Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. | 2005 Nov |
2 |